Author
Listed:
- Stefan Kol
(The Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Building 220, Kemitorvet)
- Daniel Ley
(The Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Building 220, Kemitorvet)
- Tune Wulff
(The Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Building 220, Kemitorvet)
- Marianne Decker
(The Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Building 220, Kemitorvet)
- Johnny Arnsdorf
(The Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Building 220, Kemitorvet)
- Sanne Schoffelen
(The Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Building 220, Kemitorvet)
- Anders Holmgaard Hansen
(The Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Building 220, Kemitorvet)
- Tanja Lyholm Jensen
(The Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Building 220, Kemitorvet)
- Jahir M. Gutierrez
(The Novo Nordisk Foundation Center for Biosustainability at the University of California, San Diego, School of Medicine
Department of Bioengineering, University of California, San Diego, School of Medicine)
- Austin W. T. Chiang
(The Novo Nordisk Foundation Center for Biosustainability at the University of California, San Diego, School of Medicine
Department of Pediatrics, University of California, San Diego, School of Medicine)
- Helen O. Masson
(The Novo Nordisk Foundation Center for Biosustainability at the University of California, San Diego, School of Medicine
Department of Bioengineering, University of California, San Diego, School of Medicine)
- Bernhard O. Palsson
(The Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Building 220, Kemitorvet
The Novo Nordisk Foundation Center for Biosustainability at the University of California, San Diego, School of Medicine
Department of Bioengineering, University of California, San Diego, School of Medicine
Department of Pediatrics, University of California, San Diego, School of Medicine)
- Bjørn G. Voldborg
(The Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Building 220, Kemitorvet)
- Lasse Ebdrup Pedersen
(The Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Building 220, Kemitorvet)
- Helene Faustrup Kildegaard
(The Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Building 220, Kemitorvet)
- Gyun Min Lee
(The Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Building 220, Kemitorvet
Department of Biological Sciences, KAIST, 291 Daehak-ro, Yuseong-gu)
- Nathan E. Lewis
(The Novo Nordisk Foundation Center for Biosustainability at the University of California, San Diego, School of Medicine
Department of Bioengineering, University of California, San Diego, School of Medicine
Department of Pediatrics, University of California, San Diego, School of Medicine)
Abstract
Host cell proteins (HCPs) are process-related impurities generated during biotherapeutic protein production. HCPs can be problematic if they pose a significant metabolic demand, degrade product quality, or contaminate the final product. Here, we present an effort to create a “clean” Chinese hamster ovary (CHO) cell by disrupting multiple genes to eliminate HCPs. Using a model of CHO cell protein secretion, we predict that the elimination of unnecessary HCPs could have a non-negligible impact on protein production. We analyze the HCP content of 6-protein, 11-protein, and 14-protein knockout clones. These cell lines exhibit a substantial reduction in total HCP content (40%-70%). We also observe higher productivity and improved growth characteristics in specific clones. The reduced HCP content facilitates purification of a monoclonal antibody. Thus, substantial improvements can be made in protein titer and purity through large-scale HCP deletion, providing an avenue to increased quality and affordability of high-value biopharmaceuticals.
Suggested Citation
Stefan Kol & Daniel Ley & Tune Wulff & Marianne Decker & Johnny Arnsdorf & Sanne Schoffelen & Anders Holmgaard Hansen & Tanja Lyholm Jensen & Jahir M. Gutierrez & Austin W. T. Chiang & Helen O. Masson, 2020.
"Multiplex secretome engineering enhances recombinant protein production and purity,"
Nature Communications, Nature, vol. 11(1), pages 1-10, December.
Handle:
RePEc:nat:natcom:v:11:y:2020:i:1:d:10.1038_s41467-020-15866-w
DOI: 10.1038/s41467-020-15866-w
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:11:y:2020:i:1:d:10.1038_s41467-020-15866-w. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.